Suchergebnisse - (Subject:"Siltuximab")

PubPharm (20)

1

COVID-19 acute respiratory distress syndrome : A simulation study of the effects of combination therapy with tocilizumab and siltuximab

enthalten in: British journal of clinical pharmacology | 2022

von Doyle, E. | Bentley, D. | Dodds, M.

2

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Declercq, J. | Van Damme, K. | De Leeuw, E. | +40

CommentIn: Lancet Respir Med. 2021 Dec;9(12):1353-1354. - PMID 34756179

3

Efficacy of IL-6 antagonists in the treatment of COVID-19 patients : further randomized controlled trials are warranted

enthalten in: Human cell | 2021

von Panda, A. | Padhi, S. | Pati, A. | +1

4

Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19

enthalten in: Thorax | 2021

von Khan, F. | Stewart, I. | Fabbri, L. | +4

5

Experience with the use of siltuximab in patients with SARS-CoV-2 infection

enthalten in: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia | 2021

von Meira, F. | Albiach, L. | Carbonell, C. | +32

6

Pharmacological treatment of COVID-19 : Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)

enthalten in: Medicina intensiva | 2021

von Díaz, E. | Amézaga Menéndez, R. | Vidal Cortés, P. | +6

7

Interleukin-6 blocking agents for treating COVID-19 : a living systematic review

enthalten in: The Cochrane database of systematic reviews | 2021

von Ghosn, L. | Chaimani, A. | Evrenoglou, T. | +21

CommentIn: Ann Intern Med. 2021 Jun;174(6):JC63. - PMID 34058104

8

Antirheumatic Disease Therapies for the Treatment of COVID-19 : A Systematic Review and Meta-Analysis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2021

von Putman, M. | Chock, Y. | Tam, H. | +20

CommentIn: Arthritis Rheumatol. 2021 Sep;73(9):1765-1767. - PMID 33779073

9

Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome

enthalten in: International journal of medical sciences | 2021

von Du, P. | Geng, J. | Wang, F. | +3

10

Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease

enthalten in: Expert opinion on investigational drugs | 2020

von Zhou, Z. | Price, C.